Back to Search
SHALAKA VENKATRAMAN, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1528717113Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Port site tuberculosis: endogenous or exogenous infection?
PMID 19622026·Surg Infect (Larchmt)·2010
5-case
The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
PMID 19088300·J Pharmacol Exp Ther·2009
7-preclinical
Potent inhibitors of HCV-NS3 protease derived from boronic acids.
PMID 19022670·Bioorg Med Chem Lett·2009
8-other
Behavioral modulation of stimulus-evoked oscillations in barrel cortex of alert rats.
PMID 19521539·Front Integr Neurosci·2009
8-other
Potent aza-peptide derived inhibitors of HCV NS3 protease.
PMID 19596195·Bioorg Med Chem Lett·2009
8-other
Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent.
PMID 19581900·Nat Nanotechnol·2009
7-preclinical
Discovery of novel P3 sulfonamide-capped inhibitors of HCV NS3 protease. Inhibitors with improved cellular potencies.
PMID 19481946·Bioorg Med Chem·2009
7-preclinical
Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profile.
PMID 19371095·J Med Chem·2009
7-preclinical
A system for neural recording and closed-loop intracortical microstimulation in awake rodents.
PMID 19224714·IEEE Trans Biomed Eng·2009
7-preclinical
Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine protease.
PMID 19196021·J Med Chem·2009
7-preclinical
Design, synthesis, and evaluation of oxygen-containing macrocyclic peptidomimetics as inhibitors of HCV NS3 protease.
PMID 19154150·J Med Chem·2009
8-other
A novel nanostructured poly(lactic-co-glycolic-acid)-multi-walled carbon nanotube composite for blood-contacting applications: thrombogenicity studies.
PMID 19505600·Acta Biomater·2009
7-preclinical
Discovery and structure-activity relationship of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease.
PMID 19102654·J Med Chem·2009
8-other
Controlled release of complexed DNA from polycaprolactone film: comparison of lipoplex and polyplex release.
PMID 18823023·J Biomed Mater Res B Appl Biomater·2009
7-preclinical
Fabrication of a bi-luminophore temperature sensitive coating by embedding europium thenoyltrifluoroacetonate (EuTTA) and perylene in polystyrene.
PMID 19002573·J Fluoresc·2009
8-other
Toward the back-up of boceprevir (SCH 503034): discovery of new extended P4-capped ketoamide inhibitors of hepatitis C virus NS3 serine protease with improved potency and pharmacokinetic profiles.
PMID 19456105·J Med Chem·2009
7-preclinical
Use of a novel anti-proliferative compound coated on a biopolymer to mitigate platelet-derived growth factor-induced proliferation in human aortic smooth muscle cells: comparison with sirolimus.
PMID 18853254·Glycoconj J·2009
7-preclinical
A novel model and experimental analysis of hydrophilic and hydrophobic agent release from biodegradable polymers.
PMID 18671269·J Biomed Mater Res A·2009
8-other
The short-term effect on restenosis and thrombosis of a cobalt-chromium stent eluting two drugs in a porcine coronary artery model.
PMID 19627432·J Interv Cardiol·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1431 SW 1ST AVE
OCALA, FL 34471 - Phone
- (352) 401-1000
Quick Facts
- NPI
- 1528717113
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile